{"id":"W3214689435","doi":"10.1182/blood-2021-147360","title":"Phase II Study of Venetoclax Added to Cladribine (CLAD) and Low Dose AraC (LDAC) Alternating with 5-Azacytidine (AZA) in Older and Unfit Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Cladribine; Medicine; Internal medicine; Concomitant; Cytarabine; Gastroenterology; Myeloid leukemia; Leukemia; Chronic lymphocytic leukemia","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001382139,0.0008838889,0.001572378,0.0003955816,0.0003671351,0.0006919443,0.0007738246,0.0007231378,0.002034999],"category_scores_gemma":[0.0007536814,0.0004726937,0.0007211304,0.0003507192,0.000961425,0.000564679,0.0003045201,0.002604663,0.0004203582],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006387256,"about_ca_system_score_gemma":0.00129021,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001136011,"about_ca_topic_score_gemma":0.001862741,"domain_scores_codex":[0.9996347,0.0001743705,0.00001814895,0.00007105892,0.00002804864,0.00007370765],"domain_scores_gemma":[0.9991255,0.0001494388,0.0001087964,0.00009200547,0.00005429965,0.0004699693],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5888959,0.2175196,0.0111469,0.0004908853,0.000788694,0.0003242673,0.0005417717,0.003274434,0.09796654,0.0003438255,0.001755555,0.07695156],"study_design_scores_gemma":[0.1949851,0.7875022,0.009141929,0.00001657148,0.0002201857,0.0001702295,0.00006296983,0.001061096,0.005264556,0.00007665104,0.001479348,0.00001913696],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974385,0.0004434211,0.0002433585,0.00008331661,0.00006015366,0.000950512,0.0001982446,0.00002755601,0.0005547852],"genre_scores_gemma":[0.9954011,0.0004936489,0.001124287,0.0002402574,0.0001203379,0.0009730739,0.0006157493,0.00001295963,0.001018431],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002034999,"threshold_uncertainty_score":0.007309556,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01125397933648301,"score_gpt":0.2786961000941225,"score_spread":0.2674421207576395,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}